Login / Signup

An evaluation of the FDA adverse event reporting system and the potential for reporting bias.

Andrew D MonnotErnest S FungGoli S CompoginisKevin M Towle
Published in: Journal of cosmetic dermatology (2021)
This analysis highlights the importance of assessing potential external factors, such as negative news media coverage, that may alter reporting behaviors due to societal shifts in product-specific risk perception. Consideration of these factors in post-market surveillance programs would result in more comprehensive safety evaluations.
Keyphrases
  • adverse drug
  • public health
  • emergency department
  • health insurance
  • healthcare
  • affordable care act